These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Distinct metabolic programs established in the thymus control effector functions of γδ T cell subsets in tumor microenvironments. Lopes N; McIntyre C; Martin S; Raverdeau M; Sumaria N; Kohlgruber AC; Fiala GJ; Agudelo LZ; Dyck L; Kane H; Douglas A; Cunningham S; Prendeville H; Loftus R; Carmody C; Pierre P; Kellis M; Brenner M; Argüello RJ; Silva-Santos B; Pennington DJ; Lynch L Nat Immunol; 2021 Feb; 22(2):179-192. PubMed ID: 33462452 [TBL] [Abstract][Full Text] [Related]
4. Distribution and functions of γδ T cells infiltrated in the ovarian cancer microenvironment. Chen X; Shang W; Xu R; Wu M; Zhang X; Huang P; Wang F; Pan S J Transl Med; 2019 May; 17(1):144. PubMed ID: 31064389 [TBL] [Abstract][Full Text] [Related]
5. Promoting angiogenesis within the tumor microenvironment: the secret life of murine lymphoid IL-17-producing gammadelta T cells. Silva-Santos B Eur J Immunol; 2010 Jul; 40(7):1873-6. PubMed ID: 20549671 [TBL] [Abstract][Full Text] [Related]
6. CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma-producing gammadelta effector T cells. Haas JD; González FH; Schmitz S; Chennupati V; Föhse L; Kremmer E; Förster R; Prinz I Eur J Immunol; 2009 Dec; 39(12):3488-97. PubMed ID: 19830744 [TBL] [Abstract][Full Text] [Related]
7. Key players of immunosuppression in epithelial malignancies: Tumor-infiltrating myeloid cells and γδ T cells. Tamuli B; Sharma S; Patkar M; Biswas S Cancer Rep (Hoboken); 2024 May; 7(5):e2066. PubMed ID: 38703051 [TBL] [Abstract][Full Text] [Related]
8. Immune Effects of γδ T Cells in Colorectal Cancer: A Review. Ma R; Yuan D; Guo Y; Yan R; Li K Front Immunol; 2020; 11():1600. PubMed ID: 33013819 [TBL] [Abstract][Full Text] [Related]
9. Regulation and function of IL-17A- and IL-22-producing γδ T cells. Ness-Schwickerath KJ; Morita CT Cell Mol Life Sci; 2011 Jul; 68(14):2371-90. PubMed ID: 21573786 [TBL] [Abstract][Full Text] [Related]
10. Differences in circulating γδ T cells in patients with primary colon cancer and relation with prognostic factors. Andreu-Ballester JC; Galindo-Regal L; Hidalgo-Coloma J; Cuéllar C; García-Ballesteros C; Hurtado C; Uribe N; Del Carmen Martín M; Jiménez AI; López-Chuliá F; Llombart-Cussac A PLoS One; 2020; 15(12):e0243545. PubMed ID: 33326443 [TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis. Wakita D; Sumida K; Iwakura Y; Nishikawa H; Ohkuri T; Chamoto K; Kitamura H; Nishimura T Eur J Immunol; 2010 Jul; 40(7):1927-37. PubMed ID: 20397212 [TBL] [Abstract][Full Text] [Related]
12. γδ T Cells: Unexpected Regulators of Cancer Development and Progression. Fleming C; Morrissey S; Cai Y; Yan J Trends Cancer; 2017 Aug; 3(8):561-570. PubMed ID: 28780933 [TBL] [Abstract][Full Text] [Related]
13. Editorial: γδ T Cells in Cancer. Coffelt SB; Kabelitz D; Silva-Santos B; Kuball J; Born W; Bank I Front Immunol; 2020; 11():602411. PubMed ID: 33329597 [No Abstract] [Full Text] [Related]
14. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting. Li Y; Li G; Zhang J; Wu X; Chen X Front Immunol; 2020; 11():619954. PubMed ID: 33664732 [TBL] [Abstract][Full Text] [Related]
15. Gamma delta T cells provide an early source of interferon gamma in tumor immunity. Gao Y; Yang W; Pan M; Scully E; Girardi M; Augenlicht LH; Craft J; Yin Z J Exp Med; 2003 Aug; 198(3):433-42. PubMed ID: 12900519 [TBL] [Abstract][Full Text] [Related]
16. Aberrantly Expressed Embryonic Protein NODAL Alters Breast Cancer Cell Susceptibility to γδ T Cell Cytotoxicity. Siegers GM; Dutta I; Kang EY; Huang J; Köbel M; Postovit LM Front Immunol; 2020; 11():1287. PubMed ID: 32636849 [TBL] [Abstract][Full Text] [Related]
17. Critical Role for SLAM/SAP Signaling in the Thymic Developmental Programming of IL-17- and IFN-γ-Producing γδ T Cells. Dienz O; DeVault VL; Musial SC; Mistri SK; Mei L; Baraev A; Dragon JA; Krementsov D; Veillette A; Boyson JE J Immunol; 2020 Mar; 204(6):1521-1534. PubMed ID: 32024701 [TBL] [Abstract][Full Text] [Related]
18. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy. Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998 [TBL] [Abstract][Full Text] [Related]
19. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds. Lança T; Costa MF; Gonçalves-Sousa N; Rei M; Grosso AR; Penido C; Silva-Santos B J Immunol; 2013 Jun; 190(12):6673-80. PubMed ID: 23686489 [TBL] [Abstract][Full Text] [Related]
20. Our evolving understanding of the role of the γδ T cell receptor in γδ T cell mediated immunity. Gully BS; Rossjohn J; Davey MS Biochem Soc Trans; 2021 Nov; 49(5):1985-1995. PubMed ID: 34515758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]